MXPA04004763A - Esteres dobles. - Google Patents

Esteres dobles.

Info

Publication number
MXPA04004763A
MXPA04004763A MXPA04004763A MXPA04004763A MXPA04004763A MX PA04004763 A MXPA04004763 A MX PA04004763A MX PA04004763 A MXPA04004763 A MX PA04004763A MX PA04004763 A MXPA04004763 A MX PA04004763A MX PA04004763 A MXPA04004763 A MX PA04004763A
Authority
MX
Mexico
Prior art keywords
esters
double esters
double
alkane
therapeutic
Prior art date
Application number
MXPA04004763A
Other languages
English (en)
Spanish (es)
Inventor
Klaveness Jo
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of MXPA04004763A publication Critical patent/MXPA04004763A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/50—Sebacic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/44—Adipic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/48—Azelaic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Tires In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
MXPA04004763A 2001-11-22 2002-11-22 Esteres dobles. MXPA04004763A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0128052.8A GB0128052D0 (en) 2001-11-22 2001-11-22 Compounds
PCT/GB2002/005305 WO2003045893A1 (en) 2001-11-22 2002-11-22 Double esters

Publications (1)

Publication Number Publication Date
MXPA04004763A true MXPA04004763A (es) 2004-07-30

Family

ID=9926289

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004763A MXPA04004763A (es) 2001-11-22 2002-11-22 Esteres dobles.

Country Status (15)

Country Link
US (1) US7629383B2 (cg-RX-API-DMAC7.html)
EP (1) EP1448508B1 (cg-RX-API-DMAC7.html)
JP (1) JP4426298B2 (cg-RX-API-DMAC7.html)
KR (1) KR20040071138A (cg-RX-API-DMAC7.html)
CN (1) CN100516018C (cg-RX-API-DMAC7.html)
AT (1) ATE443695T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002343086C1 (cg-RX-API-DMAC7.html)
CA (1) CA2467773C (cg-RX-API-DMAC7.html)
DE (1) DE60233819D1 (cg-RX-API-DMAC7.html)
GB (1) GB0128052D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0402122A2 (cg-RX-API-DMAC7.html)
MX (1) MXPA04004763A (cg-RX-API-DMAC7.html)
NO (1) NO20042603L (cg-RX-API-DMAC7.html)
RU (1) RU2350599C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003045893A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
DE102006004804A1 (de) * 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
EP0125781B1 (en) 1983-04-14 1987-08-12 Interox Chemicals Limited Peroxygen compounds
GB8310080D0 (en) 1983-04-14 1983-05-18 Interox Chemicals Ltd Bleach composition
ATE74359T1 (de) * 1987-01-27 1992-04-15 Pfizer 6-beta(substituierte)-(s)hydroxymethylpenicillans|ure und deren derivate.
LU86918A1 (fr) * 1987-06-12 1989-03-08 Oreal Nouveaux diesters de l'acide azelaique,leur procede de preparation,les compositions topiques les contenant et leur utilisation dans le traitement de l'acne
CA2107106A1 (en) 1991-03-28 1992-09-29 Jo Klaveness Cross-linking agent
LV10396B (en) 1992-03-06 1996-02-20 Nycomed Imaging As Novel contrast agents
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
JP4029440B2 (ja) 1997-07-09 2008-01-09 大日本インキ化学工業株式会社 側鎖型ラジカル重合性化合物及びそれを用いた液晶デバイス

Also Published As

Publication number Publication date
AU2002343086B2 (en) 2008-01-03
ATE443695T1 (de) 2009-10-15
CN1589254A (zh) 2005-03-02
KR20040071138A (ko) 2004-08-11
US7629383B2 (en) 2009-12-08
CA2467773A1 (en) 2003-06-05
GB0128052D0 (en) 2002-01-16
AU2002343086C1 (en) 2008-06-26
JP4426298B2 (ja) 2010-03-03
AU2002343086A1 (en) 2003-06-10
RU2004118713A (ru) 2005-03-27
DE60233819D1 (de) 2009-11-05
EP1448508A1 (en) 2004-08-25
CA2467773C (en) 2011-08-16
WO2003045893A1 (en) 2003-06-05
JP2005510556A (ja) 2005-04-21
US20050203181A1 (en) 2005-09-15
CN100516018C (zh) 2009-07-22
NO20042603L (no) 2004-06-21
HUP0402122A2 (hu) 2005-02-28
RU2350599C2 (ru) 2009-03-27
EP1448508B1 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
MY127290A (en) New use of flibanserin
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
WO2004006858A3 (en) Compounds, compositions, and methods employing same
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
MXPA04005865A (es) Suministro de aminoglucosidos a los pulmones.
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
BG108516A (en) Pharmaceutical formulation
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
AUPQ866500A0 (en) Therapeutic compounds and methods
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
MXPA04004763A (es) Esteres dobles.
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
WO2005034929A3 (en) Tissue remodeling and vascularization
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
AU2001268461A1 (en) Uncoupling proteins as targets for the treatment of heart failure
GB0128071D0 (en) Medicament
AP1731A (en) Use of an inhibitor of the renin-angiotensin system for the manufacture of a medicament or prevention of lipodystrophy syndorme.